Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Global Urinary Tract Infection Testing Market Snapshot (2023 to 2033)

The global urinary tract infection testing market was valued at US$ 563.0 Million in 2022 and is expected to reach US$ 1.1 Billion by 2033. The urinalysis test with around 48.5% in terms of value share, has topped the global market within the testing category in 2022 and is expected to grow at a CAGR of close to 6.0% over the forecast period (2023 to 2033)

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 563.0 Million
Market Value 2023 US$ 593.7 Million
Market Value 2033 US$ 1.1 Billion
CAGR 2023 to 2033 6.0%
Market Share of Top 5 Countries 53.5%
Key Market Players ACON Laboratories Inc., Cardinal Health Inc., Danaher Corporation, SYSMEX CORPORATION, Abbott Laboratories, Bio-Rad Laboratories, Roche AG, LabCorp(Laboratory Corporation of America Holdings)., Stryker Corporation, Thermo Fisher Scientific, Inc.

Globally, the number of people suffering from urinary tract infections has increased. Urinary tract infection adds to the world's second-largest patient pool. The market is expected to rise because of rising UTI prevalence and desire for better treatment options. The introduction of innovative testing kits and equipment is likely to propel the urine infection testing industry forward.

  • For example, in June 2019, MiDOG, LLC announced the release of a new collection of urine kits and tests for the detection of fungal and bacterial pathogens in canine urinary tract illnesses.

With the introduction of new technologies and an increase in the number of urinary tract infection testing kits and device players, the urinary tract infection testing market is likely to expand over the upcoming years.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Urinary Tract Infection Testing Market from 2017 to 2022 Vs Market Outlook for 2023 to 2033

The global market for urinary tract infection testing was around 1.6% of the US$ 35.0 Billion of the global infectious disease diagnostics market in 2022.

One of the most prevalent bacterial infections, impacting almost 150 million individuals worldwide, is urinary tract infection. Urinary tract infection is most commonly caused by bacteria, viruses, and fungus in the urinary tract. Escherichia coli, Klebsiella species, Pseudomonas aeruginosa, Proteus species, and Enterococcus species are few bacteria that cause urinary tract infections.

  • According to the European Association of Urology, bacterial resistance to antibiotics is increasing in the region, necessitating greater research and development for innovative therapies. The urinary tract infection testing market will rise due to the latest emerging approaches.

There is a growing interest in developing creative and effective technology that can quickly and reliably identify UTIs and select the optimum antibiotic to use for a specific patient. This, along with the other factors mentioned, are projected to drive the market in the coming year.

Owed to the above factors, the global market is projected to grow at CAGR of 6.0% in forecasted period.

What are the Key Opportunities for the Urinary Tract Infection Testing Service Providers?

Recurrence of urinary tract infections is very common, even in uncomplicated cases.

  • The incidence of recurrent UTI cases accounts for 90% of the cases as per the research article published in National Institute of Health Journal, 2022.

Bacterial persistence occurs when treatment is hampered by the buildup of germs in an area that antibiotics cannot reach, such as infected stones, urethral diverticula, and infected paraurethral glands.

Urinary tract infections are also rather common in males. Prostatitis, pyelonephritis, urethritis, cystitis, epididymitis, orchitis, and infected urinary catheters are all included in the group of adult male UTIs. Due to the numerous defenses the male urinary system has, any such infections are typically linked to anatomical anomalies that frequently call for surgical repair.

The increasing incidence of chronic kidney disease, such as renal failure and bladder cancer, is driving the use of catheters and other drainage devices in patients. Patients with urinary catheters are more likely to contract a complicated UTI. This is expected to boost growth in the UTI testing market over the forecast period.

Bacteria enter the urinary system through improper catheter insertion technique or inadequate cleanliness, resulting in infection. Poor hygiene habits, such as neglecting to clean the catheter or drainage bag, might encourage bacterial development and raise the possibility of UTIs. Sometimes, catheters can cause urine to build up or stagnate in the bladder, which can foster the growth of germs. Additionally, blockages in the catheter can prevent urine from flowing normally, causing urinary stasis and a higher risk of infection. All of these factors result in a high demand for testing for UTI.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining the Demand for Urinary Tract Infection Testing?

The accuracy of UTI diagnostic tests varies, which might result in false-positive or false-negative results. This can lead to incorrect diagnosis and treatment recommendations. The limitations of existing diagnostic tests may impede their acceptance and limit the growth of the UTI testing market. The inappropriate and overuse of antibiotics in UTI care can have an impact on the need for UTI testing. Overuse of empirical antibiotic treatment without sufficient diagnostic confirmation can lessen the perceived necessity for diagnostic testing, resulting in UTI test underutilization. Efforts to promote ethical antibiotic usage and evidence-based diagnosis may influence UTI testing demand.

Urine samples are frequently required for UTI diagnostic tests. Obtaining clean-catch urine samples can be difficult, particularly in specific patient populations such as children, the elderly, or those with mobility challenges. Difficulties in collecting samples may have an impact on the accuracy and reliability of UTI tests, limiting their usage.

Country-wise Insights

Why is USA a Prominent Market for Urinary Tract Infection Testing?

The USA occupies 31.7% of market share in 2022 globally. UTI is one of the most common bacterial-caused infectious illnesses in the country. A complex urinary tract infection, which is caused by anatomical or functional abnormalities in the urinary system, can afflict anyone, regardless of gender or age.

  • According to an American Urological Association Education and Research, Inc. 2019, between 50% and 60% of women in the US will have at least one UTI in their lifetime, with approximately 10% of postmenopausal women having a UTI in the previous year.

To avoid complications and achieve optimal patient outcomes, there is a growing emphasis on precise diagnosis and effective therapy of UTIs. As healthcare professionals and patients become more aware of the necessity of diagnostic testing, the demand for UTI tests is increasing.

What Makes China a Highly Lucrative Market for Urinary Tract Infection Testing?

China expenditure on urinary tract infection testing in 2022 was US$ 32.5 Million.

Several policies and programmes have been developed by the Chinese government to enhance healthcare outcomes and minimise healthcare-associated infections, including UTIs.

One key undertaking is the promotion of infection prevention knowledge and education. The goal is to raise awareness among healthcare practitioners and patients about the danger of UTIs and the need of infection prevention.

The government provides healthcare providers with training and instruction to help them improve their knowledge and skills in preventing UTIs. They also concentrate on this effort. Furthermore, encouraging the use of infection prevention measures in healthcare facilities. As a result, China is in high demand in the testing market for urinary tract infections.

What Makes the Germany a Large Market for Urinary Tract Infection Testing?

In 2022, the Germany held a significant share in the European market and contributed around 23.1% value share in 2022. Germany has a well-developed healthcare system that places a high emphasis on diagnostic services and preventive treatment. The availability of improved healthcare infrastructure, such as diagnostic laboratories and clinics, helps to drive the UTI testing market forward. The rising prevalence of UTIs in the country contributes to the development of the UTI testing market.

UTIs are a widespread health problem in Germany, affecting a large number of people each year. UTIs are becoming more common due to factors such as an ageing population, lifestyle changes, and healthcare-associated illnesses. In Germany, this fuels the demand for UTI testing.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Test Is Predicted to Expand Rapidly Between 2023 and 2033?

By test, urinalysis held 48.5% market share in world in 2022.

Urinalysis tests are widely used. They are a simple and non-invasive approach for healthcare experts to assess numerous different elements of human health. Urinalysis is frequently used by healthcare providers to screen for or monitor several common health disorders, such as liver disease, kidney disease, and diabetes. These tests' broad applicability are the reason for their significant market share.

Why Laboratory Test Kits are Preferred Prominently in Urinary Tract Infection Testing?

The market value of laboratory test kits is representing a sizable 73.3% market share in 2022.

Most laboratories use leukocyte esterase rapid tests to replace microscopic leukocyte counts in urine. A more advanced and exact laboratory investigation of the urine validates the results of these test kits. Because of their precision, these test kits are gaining popularity and assisting in market expansion.

Which Indication Is Accelerating the Market Growth?

The Cystitis have a considerable presence in the market with market share of 58.6% in 2022. Due to the ageing population, cystitis is the most prevalent type of UTI. Cystitis is frequent in the elderly, especially when they are ill. Bladder catheters and some urinary-tract procedures may further raise the risk of cystitis.

Which End User is Benefiting the Global Market?

The hospitals have a considerable presence in the urinary tract infection testing market, accounting for 41.7% value share in 2022, and exhibiting a high CAGR of 6.5% over the forecast period. The increased use of laboratory kits in hospitals for UTI detection is resulting in more potent for the UTI treatment, as well as increased patient visits in the hospitals globally each year are aiding the growth of the market.

Competitive Landscape

Collaborations and partnerships among healthcare providers, research institutions, and technology businesses can encourage innovation and hasten urinary tract infection testing. Collaboration in research, development, and commercialization can lead to market expansion and the creation of new applications. Numerous large firms compete in the field of urinary tract infection testing. Among the well-known players in this field are:

  • May 2023, PathogenDx is prepared to introduce a microarray-based test for urinary tract infections later this year after getting its start in the cannabis, food, and COVID-19 testing markets.
  • Feb 2023, Sysmex Launches Automated Urinalysis Testing Solutions at Medlab Middle East, Revolutionising Workflow.

Similarly, recent developments related to the companies active in the urinary tract infection testing market have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as Per Urinary Tract Infection Testing Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ Million for Value, Units for Volume
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa.
Key Market Segments Covered Test, Test Kits, Indication, End User, and Region
Key Companies Profiled
  • ACON Laboratories Inc.
  • Cardinal Health Inc.
  • Danaher Corporation
  • SYSMEX CORPORATION
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Roche AG
  • LabCorp (Laboratory Corporation of America Holdings).
  • Stryker Corporation
  • Thermo Fisher Scientific, Inc.
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing Available upon Request

Key Market Segments Covered in the Urinary Tract Infection Testing Industry Research

By Tests:

  • Urinalysis
  • Urine Cultures
  • Susceptibility Testing

By Test Kits:

  • Home Test Kits
  • Laboratory Test Kits

By Indication:

  • Cystitis
  • Urethritis
  • Pyelonephritis

By End User:

  • Hospitals
  • Nephropathy Clinics
  • Diagnostic Laboratories
  • others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

What Big was the Global Urinary Tract Infection Testing Market last Year?

The overall market was valued at around US$ 563 million in 2022 end.

What will be the Growth rate in Adoption of Urinary Tract Infection Testing Services?

The adoption of urinary tract infection testing services could grow at 6% annually until 2033.

What is the Projected Global Market Value by 2033?

The global market value to cross US$ 1,100 million by 2033.

Where is the Highest Demand for Urinary Tract Infection Testing Services?

The United States alone had generated nearly 31.7% of the global demand in 2022.

Which is the Best Performing Country for Asia Pacific Market

China market accrued nearly US$ 32.5 million in 2022.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Key Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption/Usage Analysis

    4.2. Key Regulations

    4.3. Value Chain Analysis

    4.4. PESTEL Analysis

    4.5. Key Deals and Mergers

    4.6. List of Service Providers, By Key Countries

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Infectious Disease Diagnostics Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Growing Elderly Population

        5.2.2. Rise in Chronic and Infectious Disease Prevalence

        5.2.3. Rising Research and Development

        5.2.4. Enhancing Healthcare Infrastructure

        5.2.5. Government Regulations in Product Approval

        5.2.6. Increasing Incidences of Catheter Associated UTI

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Market Volume (Units) Analysis, 2017 to 2022

    6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Tests

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022

    8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Tests

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis By Tests, 2017 - 2022

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Tests, 2023 - 2033

        9.3.1. Urinalysis

        9.3.2. Urine Cultures

        9.3.3. Susceptibility Testing

    9.4. Market Attractiveness Analysis By Tests

10. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Test Kits

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Test Kits , 2017 - 2022

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Test Kits, 2023 - 2033

        10.3.1. Home Test Kits

        10.3.2. Laboratory Test Kits

    10.4. Market Attractiveness Analysis By Test Kits

11. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Indication, 2017 - 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 - 2033

        11.3.1. Cystitis

        11.3.2. Urethritis

        11.3.3. Pyelonephritis

    11.4. Market Attractiveness Analysis By Indication

12. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By End User, 2017 - 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 - 2033

        12.3.1. Hospitals

        12.3.2. Nephropathy Clinics

        12.3.3. Diagnostic Laboratories

        12.3.4. others

    12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033, By Region

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. USA

            14.3.1.2. Canada

        14.3.2. By Tests

        14.3.3. By Test Kits

        14.3.4. By Indication

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Tests

        14.4.3. By Test Kits

        14.4.4. By Indication

        14.4.5. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. USA Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast By Market Taxonomy

                14.8.1.2.1. By Tests

                14.8.1.2.2. By Test Kits

                14.8.1.2.3. By Indication

                14.8.1.2.4. By End User

        14.8.2. Canada Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast By Market Taxonomy

                14.8.2.2.1. By Tests

                14.8.2.2.2. By Test Kits

                14.8.2.2.3. By Indication

                14.8.2.2.4. By End User

15. Latin America Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Mexico

            15.3.1.2. Brazil

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

                15.3.1.4.1. By Country

                15.3.1.4.2. By Tests

                15.3.1.4.3. By Test Kits

                15.3.1.4.4. By Indication

                15.3.1.4.5. By End User

    15.4. Market Attractiveness Analysis

                15.4.1.1.1. By Country

                15.4.1.1.2. By Tests

                15.4.1.1.3. By Test Kits

                15.4.1.1.4. By Indication

                15.4.1.1.5. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. Mexico Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast By Market Taxonomy

                15.8.1.2.1. By Tests

                15.8.1.2.2. By Test Kits

                15.8.1.2.3. By Indication

                15.8.1.2.4. By End User

        15.8.2. Brazil Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast By Market Taxonomy

                15.8.2.2.1. By Tests

                15.8.2.2.2. By Test Kits

                15.8.2.2.3. By Indication

                15.8.2.2.4. By End User

        15.8.3. Argentina Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast By Market Taxonomy

                15.8.3.2.1. By Tests

                15.8.3.2.2. By Test Kits

                15.8.3.2.3. By Indication

                15.8.3.2.4. By End User

16. Europe Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. UK

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Tests

        16.3.3. By Test Kits

        16.3.4. By Indication

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Tests

        16.4.3. By Test Kits

        16.4.4. By Indication

        16.4.5. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Germany Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast By Market Taxonomy

                16.8.1.2.1. By Tests

                16.8.1.2.2. By Test Kits

                16.8.1.2.3. By Indication

                16.8.1.2.4. By End User

        16.8.2. Italy Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast By Market Taxonomy

                16.8.2.2.1. By Tests

                16.8.2.2.2. By Test Kits

                16.8.2.2.3. By Indication

                16.8.2.2.4. By End User

        16.8.3. France Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast By Market Taxonomy

                16.8.3.2.1. By Tests

                16.8.3.2.2. By Test Kits

                16.8.3.2.3. By Indication

                16.8.3.2.4. By End User

        16.8.4. UK Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast By Market Taxonomy

                16.8.4.2.1. By Tests

                16.8.4.2.2. By Test Kits

                16.8.4.2.3. By Indication

                16.8.4.2.4. By End User

        16.8.5. Spain Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast By Market Taxonomy

                16.8.5.2.1. By Tests

                16.8.5.2.2. By Test Kits

                16.8.5.2.3. By Indication

                16.8.5.2.4. By End User

        16.8.6. BENELUX Market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast By Market Taxonomy

                16.8.6.2.1. By Tests

                16.8.6.2.2. By Test Kits

                16.8.6.2.3. By Indication

                16.8.6.2.4. By End User

        16.8.7. Russia Market Analysis

            16.8.7.1. Introduction

            16.8.7.2. Market Analysis and Forecast By Market Taxonomy

                16.8.7.2.1. By Tests

                16.8.7.2.2. By Test Kits

                16.8.7.2.3. By Indication

                16.8.7.2.4. By End User

17. East Asia Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Tests

        17.3.3. By Test Kits

        17.3.4. By Indication

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Tests

        17.4.3. By Test Kits

        17.4.4. By Indication

        17.4.5. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. China Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast By Market Taxonomy

                17.8.1.2.1. By Tests

                17.8.1.2.2. By Test Kits

                17.8.1.2.3. By Indication

                17.8.1.2.4. By End User

        17.8.2. Japan Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast By Market Taxonomy

                17.8.2.2.1. By Tests

                17.8.2.2.2. By Test Kits

                17.8.2.2.3. By Indication

                17.8.2.2.4. By End User

        17.8.3. South Korea Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast By Market Taxonomy

                17.8.3.2.1. By Tests

                17.8.3.2.2. By Test Kits

                17.8.3.2.3. By Indication

                17.8.3.2.4. By End User

18. South Asia Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Indonesia

            18.3.1.3. Malaysia

            18.3.1.4. Thailand

            18.3.1.5. Rest of South Asia

        18.3.2. By Tests

        18.3.3. By Test Kits

        18.3.4. By Indication

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Tests

        18.4.3. By Test Kits

        18.4.4. By Indication

        18.4.5. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. India Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast By Market Taxonomy

                18.8.1.2.1. By Tests

                18.8.1.2.2. By Test Kits

                18.8.1.2.3. By Indication

                18.8.1.2.4. By End User

        18.8.2. Indonesia Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast By Market Taxonomy

                18.8.2.2.1. By Tests

                18.8.2.2.2. By Test Kits

                18.8.2.2.3. By Indication

                18.8.2.2.4. By End User

        18.8.3. Malaysia Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast By Market Taxonomy

                18.8.3.2.1. By Tests

                18.8.3.2.2. By Test Kits

                18.8.3.2.3. By Indication

                18.8.3.2.4. By End User

        18.8.4. Thailand Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast By Market Taxonomy

                18.8.4.2.1. By Tests

                18.8.4.2.2. By Test Kits

                18.8.4.2.3. By Indication

                18.8.4.2.4. By End User

19. Oceania Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Tests

        19.3.3. By Test Kits

        19.3.4. By Indication

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Tests

        19.4.3. By Test Kits

        19.4.4. By Indication

        19.4.5. By End User

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. Australia Market Analysis

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast By Market Taxonomy

                19.7.1.2.1. By Tests

                19.7.1.2.2. By Test Kits

                19.7.1.2.3. By Indication

                19.7.1.2.4. By End User

        19.7.2. New Zealand Market Analysis

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast By Market Taxonomy

                19.7.2.2.1. By Tests

                19.7.2.2.2. By Test Kits

                19.7.2.2.3. By Indication

                19.7.2.2.4. By End User

20. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis & Forecast By Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Türkiye

            20.3.1.3. South Africa

            20.3.1.4. Northern Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Tests

        20.3.3. By Test Kits

        20.3.4. By Indication

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Tests

        20.4.3. By Test Kits

        20.4.4. By Indication

        20.4.5. By End User

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. GCC Countries Market Analysis

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast By Market Taxonomy

                20.8.1.2.1. By Tests

                20.8.1.2.2. By Test Kits

                20.8.1.2.3. By Indication

                20.8.1.2.4. By End User

        20.8.2. Türkiye Market Analysis

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast By Market Taxonomy

                20.8.2.2.1. By Tests

                20.8.2.2.2. By Test Kits

                20.8.2.2.3. By Indication

                20.8.2.2.4. By End User

        20.8.3. South Africa Market Analysis

            20.8.3.1. Introduction

            20.8.3.2. Market Analysis and Forecast By Market Taxonomy

                20.8.3.2.1. By Tests

                20.8.3.2.2. By Test Kits

                20.8.3.2.3. By Indication

                20.8.3.2.4. By End User

        20.8.4. Northern Africa Market Analysis

            20.8.4.1. Introduction

            20.8.4.2. Market Analysis and Forecast By Market Taxonomy

                20.8.4.2.1. By Tests

                20.8.4.2.2. By Test Kits

                20.8.4.2.3. By Indication

                20.8.4.2.4. By End User

21. Market Structure Analysis

    21.1. Market Analysis By Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis (%) of Top Players

    21.4. Market Presence Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. ACON Laboratories Inc.

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Sales Footprint

            22.3.1.4. Key Financials

            22.3.1.5. SWOT Analysis

            22.3.1.6. Strategic Overview

                22.3.1.6.1. Marketing Strategy

                22.3.1.6.2. Product Strategy

                22.3.1.6.3. Channel Strategy

        22.3.2. Cardinal Health Inc.

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Sales Footprint

            22.3.2.4. Key Financials

            22.3.2.5. SWOT Analysis

            22.3.2.6. Strategic Overview

                22.3.2.6.1. Marketing Strategy

                22.3.2.6.2. Product Strategy

                22.3.2.6.3. Channel Strategy

        22.3.3. Danaher Corporation

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Sales Footprint

            22.3.3.4. Key Financials

            22.3.3.5. SWOT Analysis

            22.3.3.6. Strategic Overview

                22.3.3.6.1. Marketing Strategy

                22.3.3.6.2. Product Strategy

                22.3.3.6.3. Channel Strategy

        22.3.4. SYSMEX CORPORATION

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Sales Footprint

            22.3.4.4. Key Financials

            22.3.4.5. SWOT Analysis

            22.3.4.6. Strategic Overview

                22.3.4.6.1. Marketing Strategy

                22.3.4.6.2. Product Strategy

                22.3.4.6.3. Channel Strategy

        22.3.5. Abbott Laboratories

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Sales Footprint

            22.3.5.4. Key Financials

            22.3.5.5. SWOT Analysis

            22.3.5.6. Strategic Overview

                22.3.5.6.1. Marketing Strategy

                22.3.5.6.2. Product Strategy

                22.3.5.6.3. Channel Strategy

        22.3.6. Bio-Rad Laboratories

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Sales Footprint

            22.3.6.4. Key Financials

            22.3.6.5. SWOT Analysis

            22.3.6.6. Strategic Overview

                22.3.6.6.1. Marketing Strategy

                22.3.6.6.2. Product Strategy

                22.3.6.6.3. Channel Strategy

        22.3.7. Roche AG

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Sales Footprint

            22.3.7.4. Key Financials

            22.3.7.5. SWOT Analysis

            22.3.7.6. Strategic Overview

                22.3.7.6.1. Marketing Strategy

                22.3.7.6.2. Product Strategy

                22.3.7.6.3. Channel Strategy

        22.3.8. LabCorp (Laboratory Corporation of America Holdings).

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Sales Footprint

            22.3.8.4. Key Financials

            22.3.8.5. SWOT Analysis

            22.3.8.6. Strategic Overview

                22.3.8.6.1. Marketing Strategy

                22.3.8.6.2. Product Strategy

                22.3.8.6.3. Channel Strategy

        22.3.9. Stryker Corporation

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Sales Footprint

            22.3.9.4. Key Financials

            22.3.9.5. SWOT Analysis

            22.3.9.6. Strategic Overview

                22.3.9.6.1. Marketing Strategy

                22.3.9.6.2. Product Strategy

                22.3.9.6.3. Channel Strategy

        22.3.10. Thermo Fisher Scientific, Inc.

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Sales Footprint

            22.3.10.4. Key Financials

            22.3.10.5. SWOT Analysis

            22.3.10.6. Strategic Overview

                22.3.10.6.1. Marketing Strategy

                22.3.10.6.2. Product Strategy

                22.3.10.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Explore Healthcare Insights

View Reports

Urinary Tract Infection Testing Market